Novel Coronavirus (SARS-CoV-2/COVID-19)
The National Institutes of Health Oct. 13 announced a study designed to identify promising COVID-19 therapies and investigational drugs that merit larger clinical trials.
The Centers for Disease Control and Prevention added vaccine information to its COVID-19 webpage.
The Food and Drug Administration Oct. 13 issued and immediately implemented enforcement policy for modifications to FDA-cleared molecular influenza and RSV tests during the COVID-19 public health emergency to expand access to certain FDA-cleared molecular tests for detecting and identifying flu…
The NFL Players Association and AHA teamed up on a PSA to encourage individuals to wear masks to protect against COVID-19.
Ask Your Representatives to Sign ‘Dear Colleague’ Letter Urging HHS to Reinstate June COVID-19 Provider Relief Fund Reporting Requirements
Please contact your representatives today and ask them sign on to a “Dear Colleague” letter to the Department of Health and Human Services (HHS) urging it…
The Centers for Disease Control and Prevention Oct. 22 at 2 p.m. ET will host a Clinician Outreach and Communication Activity webinar on improving clinicians’ understanding the relationship between COVID-19 and the concerns of people who use drugs or who have a substance use disorder.
The AHA released a public service announcement urging the American public not to delay getting the preventive, scheduled and emergency services they need, and noting that hospitals and health systems are always there, ready to care. The PSA, available in English and Spanish, can be adapted by AHA…
A new poll by Gallup is showing sharp declines in Americans’ willingness to be vaccinated for the SARS-CoV-2 coronavirus.
The Food and Drug Administration Oct. 12 issued an emergency use authorization for Abbott Laboratories’ AdviseDx SARS-CoV-2 IgM (Immunoglobulin M) lab-based serology test.
Drug maker Johnson & Johnson Oct. 12 announced the pause of its large-scale, pivotal, multi-country phase 3 trial for its JNJ-78436735 COVID-19 vaccine candidate.